PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $617,418 | +481.3% | 25,619 | +155.0% | 0.00% | – |
| Q4 2022 | $106,207 | +658.6% | 10,048 | +225.3% | 0.00% | – |
| Q3 2022 | $14,000 | -41.7% | 3,089 | -50.2% | 0.00% | – |
| Q2 2022 | $24,000 | -71.4% | 6,209 | -45.7% | 0.00% | – |
| Q1 2022 | $84,000 | -19.2% | 11,445 | -38.0% | 0.00% | – |
| Q4 2021 | $104,000 | -69.2% | 18,453 | -65.0% | 0.00% | – |
| Q3 2021 | $338,000 | +118.1% | 52,768 | +187.2% | 0.00% | – |
| Q2 2021 | $155,000 | +49.0% | 18,374 | +86.2% | 0.00% | – |
| Q1 2021 | $104,000 | -58.2% | 9,870 | -32.9% | 0.00% | – |
| Q4 2020 | $249,000 | +130.6% | 14,716 | +74.6% | 0.00% | – |
| Q3 2020 | $108,000 | -98.7% | 8,428 | -98.5% | 0.00% | -100.0% |
| Q2 2020 | $8,188,000 | +6723.3% | 580,322 | +4346.6% | 0.01% | – |
| Q1 2020 | $120,000 | +122.2% | 13,051 | +258.2% | 0.00% | – |
| Q4 2019 | $54,000 | – | 3,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |